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Abstract
The actinomycetes are Gram- positive bacteria belonging to the order Actinomycetales within the phylum Actinobacteria. They 
include members with significant economic and medical importance, for example filamentous actinomycetes such as Strep-
tomyces species, which have a propensity to produce a plethora of bioactive secondary metabolites and form symbioses with 
higher organisms, such as plants and insects. Studying these bacteria is challenging, but also fascinating and very rewarding. 
As a Microbiology Society initiative, members of the actinomycete research community have been developing a Wikipedia- style 
resource, called ActinoBase, the purpose of which is to aid in the study of these filamentous bacteria. This review will highlight 
10 publications from 2019 that have been of special interest to the ActinoBase community, covering 4 major components of 
actinomycete research: (i) development and regulation; (ii) specialized metabolites; (iii) ecology and host interactions; and (iv) 
technology and methodology.
INTRODUCTION
The order Actinomycetales (commonly referred to as 
actinomycetes) is a group within the Gram- positive phylum 
Actinobacteria containing genera of filamentous bacteria 
such as Amycolatopsis, Micromonospora, Pseudonocardia, 
Saccharopolyspora and Streptomyces species and unicellular 
bacteria such as Corynebacterium and Mycobacterium species 
[1]. The name actinomycete derives from the ancient Greek 
ἀκτίς (aktís, ‘ray’) and μύκης (múkēs, ‘mushroom or fungus’) 
after the mycelium formation and hyphal tip extension- driven 
growth [2, 3]. Members of the order Actinomycetales show 
considerable physiological diversity. Most actinomycetes are 
aerobic, saprophytic micro- organisms with complex lifecycles 
(Fig. 1) but, as always, exceptions frequently occur [4].
Actinomycetes are ubiquitous in the environment and are 
capable of both solitary inhabitation and forming symbioses, 
not only with other micro- organisms but also higher- order 
creatures [5]. In addition to this actinomycetes, and in 
particular members of the genus Streptomyces, are prolific 
producers of specialized metabolites. These bacteria have 
proven a bountiful source of bioactive chemicals, contributing 
two- thirds of the clinically applicable antibiotics and a wide 
range of industrially important enzymes [6]. Biosynthesis of 
these natural products is intrinsically linked to the organ-
isms’ complex developmental life cycle, with the majority 
of production in Streptomyces species coinciding with the 
transition from vegetative to aerial hyphal growth. This 
progression can occur due to numerous factors, including 
nutrient deprivation, abiotic stress or microbial competition, 
requiring complex regulatory systems to control development 
and specialized metabolite biosynthesis [7].
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However, research on actinomycetes can be challenging due 
to a few key attributes. Developmental cycles can last weeks or 
months, prolonging common research practices. The GC- rich 
genome impedes routine molecular techniques, whilst abun-
dant repeat regions complicates genome sequencing and 
assembly [8, 9]. In general, there is a scarcity of specialized 
tools and techniques for non- model organisms, frustrating 
research efforts.
ActinoBase (https:// actinobase. org) is a Microbiology 
Society- supported initiative that has been launched with the 
aim of developing and distributing knowledge and resources 
pertaining to the study of filamentous actinomycetes, built by 
the research community for new and existing actinomycete 
researchers. Beyond the collation of information, it is the 
basis of a drive to connect the global filamentous actinomy-
cete research community, which meets approximately every 
3 years at the International Symposium on the Biology of 
Actinomycetes (ISBA). ActinoBase purposefully excludes the 
Mycobacteriaceae, as researchers on this bacterial family have 
already developed numerous specialized tools and resources 
within their own community [10].
To exemplify the four main avenues of filamentous actino-
mycete research, this review has been split into four sections: 
(i) development and regulation; (ii) specialized metabolites; 
(iii) ecology and host interactions; and (iv) technology 
and methodology. The purpose of this review is to feature 
publications that we, the early- career researchers who have 
established ActinoBase, believe to be of special interest to 
the actinomycete research community. We do not intend to 
highlight the ‘top’ papers of 2019 by any metric. We hope to 
use this opportunity as a lens through which we can highlight 
the breadth and intrigue contained within the actinomycete 
research field, and to provide an overview of what studying 
these organisms can entail.
Development and regulation
Streptomycetes possess a fascinating and complex develop-
mental life cycle that links cell differentiation with specialized 
metabolism. These morphological and metabolic progressions 
require tight, multi- layered regulation to detect external and 
internal stimuli and thus trigger cellular responses. As part 
of the ongoing interest in the regulatory networks of strepto-
mycetes, 2019 saw new reviews on different signal transduc-
tion mechanisms in this genus. McLean and colleagues [11] 
screened the genomes of 93 fully sequenced streptomycetes 
for two- component systems (TCSs) and found 15 that were 
conserved across all species. Their analysis of recent literature 
revolved around these 15 conserved TCSs plus 7 others of 
interest and highlighted the rapid progress in this area in 
recent years. For another signalling mechanism, Latoscha 
et al. [12] compiled information on the four nucleotide 
secondary messengers known to date in Streptomyces species 
– (p)ppGpp, cAMP, c- di- AMP and 3′,5′-cyclic diguanylic 
acid (c- di- GMP) – and summarized findings on the enzymes 
responsible for their synthesis and degradation, the effector 
molecules and the subsequent cellular response triggered by 
these signalling cascades.
c-di-GMP arms an anti-σ to control progression of 
multicellular differentiation in Streptomyces [13]
In line with the review by Latoscha et al. [12], a seminal 
study by Gallagher and colleagues [13] demonstrated that 
a secondary messenger, c- di- GMP, plays an essential role 
during sporulation in Streptomyces species.
During the later stages of development, the sporulation- 
specific σWhiG plays a key role in controlling the differentiation 
of aerial hyphae into spores. To investigate the role played 
by σWhiG, Gallagher et al. deleted whiG in Streptomyces vene-
zuelae, which resulted in an oligosporogenous phenotype. 
Conversely, overexpression of the σ factor resulted in hyper-
sporulation. Combining chromatin immunoprecipitation 
sequencing (ChIP- seq) with transcriptional profiling, it was 
revealed that σWhiG controlled the expression of whiH, whiI 
and vnz_15005. The first two of these genes are late devel-
opmental genes, whilst vnz_15005 encodes for a membrane 
protein of unknown function [13]. The authors also identi-
fied the corresponding anti-σ factor to σWhiG, RsiG, which 
was shown to form a direct complex together and regulates 
σWhiG activity. Interestingly, RsiG showed no homology to 
any previously identified anti-σ factor, so the mechanism of 
binding was unclear. To address this, Gallagher et al. deter-
mined the crystal structures of the complex, revealing a 1 : 1 
ratio of RsiG to σWhiG. The structures also revealed that the 
secondary messenger, c- di- GMP, was key to the complex by 
Fig. 1. The life cycle of filamentous actinomycetes based upon the 
model organism S. venezuelae. Development begins with the formation 
of one or two germ tubes from a spore. Following germination, mycelial 
outgrowth leads to the formation of vegetative mycelium. Transition 
from vegetative growth to aerial hyphae production occurs upon 
detection of signals, e.g. nutrient depletion. The aerial hyphae septate 
and mature into chains of pigmented spores that disperse, and the 
cycle can then begin again.
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linking the two proteins together. Further, c- di- GMP was 
found to be in a novel symmetrical dimeric form, mediating 
not only contact, but also correct forming of the RsiG loop 
around σWhiG. Finally, fluorescent polarization- based binding 
experiments revealed that RsiG discriminates between c- di-
 GMP and closely related molecules, including c- di- AMP, 
with key arginine and aspartic acid residues controlling this 
interaction [13].
Whilst previous work had established the link between c- di-
 GMP and the master regulator of aerial hyphae formation 
(BldD, 14), the results of Gallagher and colleagues’ study 
confirm that c- di- GMP is not only a key modulator of the 
last stages of the developmental progression, but also a central 
repressor of development in Streptomyces species. These find-
ings support the results of two other papers published in 2019 
that explore the role of enzymes involved in the synthesis of 
c- di- GMP in the developmental programme of streptomy-
cetes [15] and the effect of overexpressing them to increase 
the yield of erythromycin in Saccharopolyspora erythraea [16].
Gallagher and colleagues’ work also identified a new class of 
anti-σ factor and described the first example of c- di- GMP 
targeting a σ–anti-σ factor pair in Streptomyces species. 
However, the question remains as to what exactly the acti-
vating signal is for the production and degradation of nucleo-
tide second messengers such as c- di- GMP [13].
Silencing of specialized metabolism in Streptomyces by 
the nucleoid-associated protein Lsr2 [17]
Streptomyces biosynthetic gene clusters (BGCs) encoding 
the production of specialized metabolites are activated by 
pathway- situated regulators that are controlled by transcrip-
tion factors. However, only a small fraction of BGCs are tran-
scribed under normal laboratory conditions [18], resulting in 
a bottleneck in the specialized metabolites discovery process. 
The roles of several pathway- situated regulators in special-
ized metabolite production have been previously identified. 
For example, the production of actinorhodin in Streptomyces 
coelicolor is regulated by ActII-4 [19] and CprB [20]. There 
are also an increasing number of examples of coordinate 
regulation from one cluster- situated regulator on another 
BGC [21], such as with FscRI regulating both candicidin 
and antimycin production in Streptomyces albidoflavus S4 
[22]. Lsr2 is a global transcriptional regulator conserved 
throughout the phylum Actinobacteria that plays an impor-
tant role in the repression of gene expression. However, until 
now, Lsr2 has mainly been studied in Mycobacterium spp. 
[23].
Gehrke et al. report that all streptomycetes encode two 
nucleoid- associated proteins, Lsr2 and Lsr2- like (LsrL), 
and that these are involved in Streptomyces gene regulation. 
The authors also show that Lsr2 plays an important role in 
secondary metabolism. A total of 223 Lsr2- binding sites were 
found distributed throughout the S. venezuelae chromosome 
(mainly across the core region) and it was shown that Lsr2 
binds DNA to repress gene expression. Furthermore, it was 
demonstrated that Lsr2 plays a major role in repressing the 
gene expression from sequences with significantly higher AT 
content [17].
The biological roles of Lsr2 and LsrL were studied in four S. 
venezuelae strains; the wild- type strain alongside Δlsr2, ΔlsrL 
and ∆lsr2∆lsrL mutant strains. It was found that deleting lsrL 
and lsr2 from the chromosome of S. venezuelae had minor 
effects on development. However, deleting lsr2 significantly 
affected S. venezuelae’s specialized metabolism, including a 
stark increase in melanin production compared to the wild- 
type [17]. A total of 484 genes displayed altered expression in 
the lsr2 mutant strain when compared to the wild- type strain 
and the expression of 90 % of these genes was upregulated. 
It was observed that Lsr2 is directly involved in secondary 
metabolism of S. venezuelae by repressing the transcription 
of cryptic BGCs. Of the 484 genes with altered expression, 
155 correlated with BGCs that encode the production of 
specialized metabolites [17]. For example, it was observed 
that the increased melanin production correlated with an 
increased expression of genes within the melanin biosynthetic 
gene cluster. As reported in the paper, these results suggest 
that Lsr2 represses the activity of both well- conserved and 
newly acquired BGCs under normal laboratory conditions, 
explaining the ‘silencing’ of many BGCs and their ‘awakening’ 
under specific conditions [17].
Further liquid chromatography/mass spectrometry (LC- 
MS) analysis revealed that the four different strains used 
in this study produced a strain- specific chemical profile. It 
was observed that the lsr2 deletion significantly increased 
the production of specialized metabolites when compared 
to the wild- type, many of which were novel. Furthermore, 
lsr2 deletion promoted the production of otherwise cryptic 
metabolites in a wide range of Streptomyces species. In 
summary, deletion of lsr2 upregulated cryptic BGCs, which 
enabled the production of new specialized metabolites [17]. 
Together with previous reports [24], this study demonstrated 
the importance of deleting the global regulatory gene lsr2 to 
induce novel antibiotic production in Streptomyces species 
[17].
These featured publications highlight the complexity of 
actinomycete regulatory systems in both development and 
secondary metabolism. As has been highlighted above, the 
ability to perturb development and regulatory elements 
has repeatedly led to the production of novel specialized 
metabolites. However, the exploitation of this can be greatly 
improved with a better understanding of the basic underlying 
mechanisms of regulation, an area where more research is 
dearly required.
Specialized metabolites
Advances in microbial genome sequencing have revealed 
that bacteria are capable of producing many more natural 
products than are currently characterized, and actinomy-
cetes such as Streptomyces species are particularly talented 
producers of secondary metabolites [25, 26]. Whilst many 
of these compounds are antimicrobial, they can also be anti-
cancer, antiviral or immunosuppressive in activity. However, 
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identifying novel molecules remains a challenge. Traditional 
activity- based screening of microbial extracts often results 
in the rediscovery of already known compounds, and there-
fore novel approaches to natural product discovery are now 
required [27].
Salinipeptins: integrated genomic and chemical 
approaches reveal unusual d-amino acid-containing 
ribosomally synthesized and post-translationally 
modified peptides (RiPPs) from a Great Salt Lake 
Streptomyces sp. [28]
One exciting avenue of natural product research is the isola-
tion of bacteria from unique environments in order to study 
their biosynthetic potential. A study by Shang et al. achieved 
this by isolating several actinomycetes from the hypersaline 
environment of the Great Salt Lake. Interestingly, these 
isolates were closely related to bacteria that have been identi-
fied from marine environments, based on 16S rRNA gene 
sequencing. The genome of one of these halotolerant isolates, 
Streptomyces sp. GSL- 6C, was sequenced and analysed, 
leading to the identification of a BGC encoding for produc-
tion of linaridins, a rare subfamily of ribosomally synthesized 
and post- translationally modified peptides (RiPPs, 26).
RiPPs are a structurally diverse class of natural products that 
display a range of important bioactivities such as antimicro-
bial and anticancer activity. These compounds are produced 
from a small precursor peptide that is synthesized on the ribo-
some and post- translationally modified by a series of tailoring 
enzymes [29]. Intriguingly, RiPP BGCs have historically been 
difficult to detect with genome mining, and recent studies are 
starting to reveal the vast untapped biochemical diversity of 
these compounds [30, 31].
The linaridin RiPP subfamily comprises only three character-
ized examples: cypemycin [32], grisemycin [33] and legona-
ridin [34]. Among other post- translational modifications 
(PTMs), these compounds feature rare N- terminal methyla-
tions that are essential for their antibiotic activity [35].
Streptomyces sp. GSL- 6C was subjected to large- scale cultiva-
tion in saline nutrient medium in order to isolate the peptides 
produced by the identified BGC. This led to the isolation 
of four modified peptides, named salinipeptides. Nuclear 
magnetic resonance (NMR) spectra for the major peptide, 
salinipeptide A, suggested that the peptide had undergone 
significant modifications. A combination of genetic informa-
tion, NMR and mass spectrometry data allowed validation 
of the amino acid sequence, which included 15 proteino-
genic and 6 nonproteinogenic amino acids. The absolute 
configurations of the amino acids were confirmed with an 
advanced Marfey’s analysis, which revealed that several of 
the residues were of d- configuration. The salinipeptides 
were the first reported members of linaridins to harbour d- 
amino acids and, furthermore, d- proline residues have not 
been reported for any known RiPPs. Further analysis into the 
possible mechanism of amino acid isomerization suggested 
that novel enzymology may be involved in the generation 
of salinipeptide d- amino acids, as homologues of known 
isomerases could not be identified in the Streptomyces sp. 
GSL- 6C genome [28]. As well as amino acid reconfigura-
tion, additional PTMs in salinipeptide A include formation 
of an aminovinyl- cysteine end group and dehydration of 
threonine residues to dehydrobutyrine (Dhb). Salinipeptide 
A undergoes N- terminal oxidation to yield salinipeptide B, 
followed by proposed oxidation, dehydration or elimination 
and cyclization to yield salinipeptide C. Salinipeptide D only 
differs from A by the presence of one threonine residue that 
is not dehydrated to Dhb. As well as interesting structural 
features, salinipeptide A also displayed some antibacterial 
activity against Streptococcus pyogenes [28].
Overall, this work by Shang et al. shows how integrated 
genomic and chemical analyses can be applied to uncover 
novel natural products from actinomycetes isolated from 
unique environmental niches, approaches that could be 
crucial to uncovering new antibiotics in the future. Further-
more, identification of novel enzymology helps to shed light 
on the complex biosynthetic machineries employed in nature 
to produce structurally diverse molecules.
Characterization of the mode of action of aurodox, a 
type III secretion system inhibitor from Streptomyces 
goldiniensis [36]
Work published early in the year showed the potential of 
identifying novel roles for previously shelved natural prod-
ucts, with McHugh et al. characterizing the anti- virulence 
activity of aurodox [36]. First purified from S. goldiniensis 
in the 1970s, aurodox was shown to possess only weak anti-
microbial activity from its ability to bind elongation factor 
Tu and inhibit protein synthesis [37], and so the molecule 
never made it into clinical use. In 2011 aurodox was identified 
as a potent inhibitor of the type III secretion system (T3SS) 
in enteropathogenic Escherichia coli (EPEC) and was able to 
protect mice from T3SS- mediated pathogenesis from Citro-
bacter rodentium [38], sparking interest in developing the 
molecule as a candidate anti- virulence drug. In their work, 
McHugh et al. identified the mechanism by which aurodox is 
able to inhibit the T3SS. Even at the highest concentrations, 
5 µg ml−1, aurodox was unable to inhibit EPEC or C. rodentium 
cell viability. This suggested that T3SS was inhibited inde-
pendently of any growth defects. Using an in vitro infection 
assay, it was discovered that aurodox inhibits the ability of 
enterohemorrhagic E. coli (EHEC) to attach and efface HeLa 
epithelial cells. Indeed, in the presence of aurodox a 36 % 
reduction of infection and effacing lesions was observed, 
resulting in a >3 log reduction in EHEC colonization. 
Whole- transcriptome analysis revealed that aurodox inhibits 
the expression of numerous virulence genes, including the 
locus of enterocyte effacement (LEE) pathogenicity island. 
Aurodox also downregulates the expression of ler, a master 
regulator of T3SS. Conversely, McHugh et al. demonstrated 
that inhibition of the TS33 by aurodox could be overcome 
by overexpression of ler. Finally, it was shown that aurodox 
does not trigger the EHEC SOS response or induce Shiga 
toxin expression in C. rodentium. The SOS response and 
subsequent expression of shiga toxin in EHEC cases can lead 
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to life- threatening haemolytic uremic syndrome. Therefore, it 
is clinically relevant that aurodox can inhibit the TS33 without 
inducing these responses [36].
Although the exact target of aurodox remains to be elucidated, 
this work highlights its potential as a clinical anti- virulence 
compound. In the context of the current antimicrobial 
resistance crisis [39], the development of novel strategies to 
combat infection is paramount, with the discovery and char-
acterization of anti- virulence compounds being one of these 
strategies. It is very possible that resistance to T3SS suppres-
sion has already evolved, and thus worthwhile to carry out 
further investigation into the mechanism of ler repression 
by aurodox, the possible mechanisms by which resistance 
to aurodox could arise, and the evolution and chemistry of 
aurodox biosynthesis [36].
This work by McHugh et al. demonstrates the value of rein-
specting molecules that may be non- viable as clinical anti-
microbial agents alongside the methodology for the complex 
task of characterizing mechanisms of virulence inhibition.
Phylogenetic reconciliation reveals the natural history of 
glycopeptide antibiotic biosynthesis and resistance [40]
With an increase in the quantity of publicly available micro-
bial genomic data, numerous bioinformatic tools have been 
developed to help us understand gene functions and mine 
for novel BGCs [41]. These genomic data can also be lever-
aged to study the phylogenetics of biosynthetic genes, to give 
insights into how particular natural product pathways might 
have evolved.
A study by Waglechner et al. demonstrated the use of phylo-
genetic reconciliation in order to understand the origin and 
evolution of glycopeptide antibiotics (GPAs), a class of actino-
mycete natural product that includes last- line- of- defence 
antibiotics such as vancomycin and teicoplanin [40].
GPAs are glycosylated peptides synthesized by non- ribosomal 
peptide synthetases (NRPS). They target cell wall synthesis 
of Gram- positive bacteria by binding to the acyl- d- alanyl- 
d- alanine terminus of the growing peptidoglycan chain. 
GPAs share a common heptapeptide scaffold containing 
aromatic amino acids that are subject to extensive oxida-
tive crosslinking. Further tailoring reactions are carried out 
after release from the NRPS machinery, to introduce sugar 
residues, chlorination and lipid chains [42, 43]. Alongside 
these tailoring enzymes, GPA BGCs also include genes for 
resistance, regulation and export. As these features are not 
conserved in all GPA BGCs, their evolutionary roles are diffi-
cult to study in isolation, but comparative analysis of several 
BGCs can provide reconstruction of the natural history of 
GPAs [40].
Waglechner et al. compared 71 GPA BGCs from 8 genera of 
Actinobacteria, which were used to construct multiple species 
phylogenies. The phylogeny of each GPA gene and domain 
was separately compared with a dated species tree to identify 
evolutionary milestones of GPA BGCs using phylogenetic 
reconciliation [40].
This approach showed that GPA precursor biosynthesis, 
as well as ancestors of export and regulation, are the most 
ancient components of GPA BGCs, at over 1 billion years 
old. This includes enzymes responsible for the genera-
tion of non- proteinogenic amino acid precursors, such as 
3- deoxy- d- arabinoheptulosonate 7- phosphate synthase 
(DAHPS), chorismate mutase (CM) and prephenate dehy-
drogenase (Pdh), which therefore predate their incorporation 
into GPA BGCs. The fact that these precursors are older than 
other pathway components suggests that GPA BGCs arose 
from a pre- existing pool of genes [40].
In contrast, resistance is relatively contemporary. Most GPA 
BGCs contain the vanHAX genes for self- resistance, and the 
reconciled roots of these genes map from 140 million years 
ago (Ma) for vanA to 404 Ma for vanH and vanX. Specific 
tailoring enzymes also have some of the youngest reconciled 
dates: the crosslinking P450 enzymes OxyA, C and E arose 
202 Ma within Nonomuraea, along with acylation; glycosyla-
tion arose 224 Ma and halogenation arose 731 Ma within 
Amycolatopsis. The structurally central heptapeptide scaffold 
was also shown to arise 300–500 Ma [40].
Overall, this work puts antibiotic biosynthesis and resistance 
into an evolutionary context, and builds on previous studies 
that were limited to phylogenies of specific marker genes 
[44, 45]. The study of GPA evolution gives valuable insights 
into how new molecules arise in nature, and is also important 
for guiding bioengineering approaches for the production and 
discovery of potential new antibiotics in the future [45, 46].
These studies highlight a diverse range of methodologies that 
can be applied to identify new antibiotics and explore the 
clinical potential of known natural products. From isolating 
novel bacteria from unique environments, investigating the 
activities of known molecules and learning biosynthetic 
lessons from evolution, combined these approaches can 
help uncover the wide- ranging functions of metabolites 
produced by actinomycetes, and how these molecules are 
biosynthesized.
Ecology and host interactions
Actinomycetes are an ecologically diverse group, able to 
occupy a huge range of environments and niches. This is 
exemplified by the breadth of habitats actinomycetes were 
detected in and isolated from in 2019, ranging from marine 
sediments in the Arctic and Antarctic [47] to tropical 
mangrove sediments in India [48]. They have been found in 
wetlands [49], hyper- arid Atacaman desert soils [50], under-
ground in Shuanghe cave systems [51] and in Himalayan 
mountain pine forests [52]. In addition, actinomycetes are 
frequently found associated with a host organism, forming 
symbiotic relationships with insects such as bees [53], fungus- 
farming ants and pine beetles [54]. They can also be associated 
with plants, ranging from the economically important cereal 
crop wheat (Triticum aestivum, 53) to the Japanese black pine 
tree [55]. The varied ecology of actinomycetes provides a deep 
well of biological intrigue and has led to important discoveries 
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such as new antibiotics [47, 54] and agricultural biocontrol 
applications [56, 57].
Awakening ancient polar Actinobacteria: diversity, 
evolution and specialized metabolite potential [47]
Actinomycetes produce a plethora of biologically active and 
chemically diverse metabolites that provide over two- thirds of 
antibiotics. Marine polar and sub- polar environments, which 
have been largely understudied due to their extreme climate, 
may yield previously undiscovered actinomycetes with novel 
antimicrobial metabolites. Indeed, 454 sequencing of bacteria 
from Arctic sediment samples found that 10 % of the bacterial 
community were Actinobacteria [58]. These ecosystems are 
highly vulnerable to global climate change and so explora-
tion of the polar sediment microbiome may provide insights 
into the biomass, diversity and community composition of 
microbial communities in fluctuating environments. Further-
more, it has been proposed that geographical isolation may 
determine bacterial population structure, and investigation 
into the relationship between community composition, func-
tional genes and sediment depth may elucidate more about 
actinomycete evolution and ecology [47].
This study, performed by Millán- Aguiñaga et al., attempted 
to isolate rare actinomycetes from sediment cores retrieved 
from Artic and sub- Artic environments using both culture- 
dependent and metagenomic investigation in order to isolate 
specialized metabolite production. The study obtained 12 
previously undisturbed sediment cores sourced from both 
the Antarctic and the Artic in a manner that endeavoured 
to preserve the sediment–water interface and consistent 4 °C 
temperature. These sediment cores were anaerobic, whilst 
the 50 actinomycete- like strains isolated from the sediment 
were cultured aerobically, suggesting that spores may be 
metabolically inactive. Of the isolated strains, 78 % belonged 
to the phylum Actinobacteria, with some rare actinomycetes, 
including 25 Antarctic Pseudonocardia strains. Sequencing of 
the 16S rRNA gene and phylogenetic analysis demonstrated 
that KRD-291, 1 of the 25 Pseudonocardia strains isolated, 
was related to Pseudonocardia sediminis, a species previously 
isolated from South China Sea sediment [59]. The remaining 
Pseudonocardia isolates were most closely related to the type 
strains of Pseudonocardia petrolephila and Pseudonocardia 
serianimatus, but sequence similarity values suggest that 
many may represent novel species. Radiocarbon dating of 
one core, the Artic sediment core GC067, dated it at between 
8287 (upper) and 26 000 (lower) years old. From this, three 
genera of Actinobacteria were isolated, Halomonas, Micro-
bacterium and Rhodococcus. Additionally, more potentially 
novel species were isolated from an Antarctic core, belonging 
to the genera Agrococcus and Salinibacterium. Following 
DNA extraction, MinION sequencing was performed for 
metagenomic analysis in order to investigate the bacterial 
diversity within the cores. This revealed that bacterial reads 
comprised between 1–5 % of total reads and Actinobacteria, 
including Microbacterium, were found to be present in both 
sediment cores, but in higher in abundance within Artic 
sediment [47].
To investigate the biochemical potential of the isolates, 15 
strains belonging to the genera Pseudonocardia, Microbacte-
rium, Agrococcus, Rhodococcus and Pseudomonas were chosen 
based on location and phylogeny. The strains were screened 
for bioactivity against both Gram- positive and Gram- negative 
bacterial pathogens. Although no antimicrobial activity was 
detected, analysis of the tandem mass spectrometry (MS/
MS) data at the genus level resulted in a molecular network 
comprising 1652 nodes. Further investigation into the 
Pseudonocardia strains isolated from the upper, middle and 
lower sections of sediment core BC043 revealed consider-
able chemical diversity across core depth, and therefore time, 
suggesting that sediment depth influences chemical diversity 
[47].
The study concludes that polar bacteria may have consider-
able chemical potential, with the biochemical profile of these 
isolates suggesting that many of these metabolites may be 
novel natural products.
Local adaptation of bacterial symbionts within a 
geographic mosaic of antibiotic coevolution [60]
In addition to extreme and unexplored habitats, novel 
antibiotics can be found in host- associated systems [5]. 
For example, the Pseudonocardia- dominated actinomycete 
community associated with fungus- farming leafcutter ants 
produce a range of antifungal and antibacterial compounds, 
such as the antifungal nystatin P1 [61]. Fungus- farming ants 
depend entirely on their fungus garden (Leucoagaricus gongy-
lophorus) as a source of food. This fungus can be susceptible 
to infection by specialized fungal pathogens from the genus 
Escovopsis. By utilizing the antifungal secondary metabolism 
of their actinomycete symbionts, the ants can protect the 
fungus garden from Escovopsis infection. Other ant species 
have also been shown to cultivate fungus, including the 
African plant ant Tetraponera penzigi, and the exploration of 
this symbiosis led to the discovery of an entirely new class of 
antibiotic compounds called formicamycins, demonstrating 
the potential contained within these unique ecological inter-
actions [62].
It is thought that fungus- farming ants have been challenged 
by Escovopsis infections for much of the ~55 million years 
that they have been cultivating L. gongylophorus, and have 
likely been utilizing the antifungal capabilities of actinomy-
cete symbionts for millions of years [63]. Despite this, little 
is known about the coevolutionary history of this symbiosis. 
Caldera et al. aimed to place this system within an evolu-
tionary framework by testing whether the coevolution occur-
ring between the Pseudonocardia symbiont and the Escovopsis 
nest pathogen fits the geographic mosaic theory of coevolu-
tion (GMC). The GMC framework suggests that coevolution 
will vary among different populations of leafcutter ants 
depending on local geography and ecology. Previous work 
from the group showed that the extent of Escovopsis inhibition 
in vitro is proportional to the ability of Pseudonocardia to 
suppress the disease in vivo [64]. Using this principle, they 
tested the ability of 52 Pseudonocardia strains (isolated from 
different ant colonies across Central America) to inhibit 
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different strains of Escovopsis. They found greater inhibi-
tion of an Escovopsis strain correlated with its abundance in 
leafcutter ant nests, indicating that Pseudonocardia spp. are 
generally more adapted to suppress the most common strains 
of the pathogen.
To understand how well adapted Pseudonocardia strains 
are, Caldera et al. conducted a matrix bioassay, consisting 
of 2417 individual bioassays challenging different Pseudono-
cardia isolates from the Panama Canal region with Escovopsis 
strains isolated from different sites. The Panamanian canal 
isolates were less capable of inhibiting Escovopsis strains 
from Costa Rica or from a distant region of Panama. Inter-
estingly, they were also worse at inhibiting Escovopsis strains 
from Barro Colorado Island (BCI), an island formed around 
100 years ago when the Panama Canal was flooded. Further 
analysis confirmed that the BCI population is, in fact, locally 
adapted, whereas local adaptation was less present in some 
of the surrounding mainland populations. This variation in 
the extent of local adaptation is consistent with the GMC 
framework.
Lastly, they performed genomic analysis using both published 
data and whole- genome sequencing. This revealed that the 
population of Pseudonocardia symbionts and Escovopsis 
strains on BCI is, in fact, genetically distinct. Using the 29 
Pseudonocardia genomes they produced, they were also able 
to correlate the presence or absence of certain BGCs with the 
ability or inability to inhibit different Escovopsis strains. For 
example, BCI Pseudonocardia have gained a unique bacteri-
ocin cluster, which is likely used to inhibit other actinomy-
cete strains attempting to colonize the ants. They have also 
acquired a mutation in a gene within an NRPS BGC. This 
shows that horizontal gene transfer is not the only mode by 
which Pseudonocardia spp. can adapt to combat Escovopsis 
strains, and that selection can still favour beneficial genomic 
mutations.
Overall, this study takes a comprehensive look at the 
evolutionary dynamics governing the interaction between 
symbiotic Pseudonocardia strains and the Escovopsis nest 
pathogen. They manage, for the first time, to apply the GMC 
framework to a microbial population in order to assess local 
coadaptation between two microbes. This is a valuable way 
to understand how these populations have adapted and has 
revealed that populations that are more isolated can carry 
distinct BGCs. This knowledge could help guide isolation 
approaches in the future to maximize the likelihood of 
finding novel antibiotics.
A mutualistic interaction between Streptomyces bacteria, 
strawberry plants and pollinating bees [65]
We have long known that actinomycetes, such as streptomy-
cetes, can occupy plant- associated niches [66] in addition 
to insect- associated niches [67], and that they can protect 
either host organism from disease [68, 69]. However, ques-
tions remain surrounding the exact nature of the relationship. 
Are streptomycete endophytes mobile within plant tissues? 
Do entophytic streptomycetes (those that can grow within 
plant tissues) influence multi- trophic interactions involving 
the host?
Kim et al. [65] begin to address these questions as they 
describe a mutualistic tri- partite interaction between Strep-
tomyces spp., strawberry plants (Fragaria x ananassa) and 
honeybees. Using 454 16S rRNA gene pyrosequencing, they 
consistently found streptomycetes within the flowers and 
pollen of strawberry plants during early life. In later life, 
however, the abundance of streptomycetes falls, a change 
that correlated strongly with the onset of grey mould disease 
(Botrytis cinerea). Interestingly, they were able to combat 
grey mould disease successfully via a topical application of 
streptomycete strains isolated from the flowers of strawberry 
plants. Typically, streptomycetes colonize the roots [66] as 
plants acquire most of their beneficial microbiota horizon-
tally from the soil community [70]. Isolation of Streptomyces 
species from aerial plant tissues (the phyllosphere) raised 
a question – how do streptomycetes migrate from the soil 
to the flowers? To address this, Kim et al. used both qPCR 
and fluorescence microscopy to show for the first time that 
Streptomyces spp. isolates are able to migrate from the roots, 
via the xylem, to colonize the stamen and the pollen granules. 
This supports a model whereby streptomycetes colonize the 
roots from the soil, and then migrate via the xylem to colonize 
the phyllosphere.
Honeybees in contact with streptomycete- containing pollen 
granules were also colonized. The honeybees benefit from 
this as bees fed pollen containing streptomycete isolates 
were significantly more resilient to infection by two bacte-
rial entomopathogens (Paenibacillus larvae and Serratia 
marcescens). Remarkably, Kim et al. also showed that bees 
can transmit Streptomyces spp. between plants. In a single 
chamber, three separate groups of strawberry plants were 
grown; one inoculated with Streptomyces bacteria and two 
uninoculated. They capped the flowers of one uninoculated 
group, blocking honeybee access. After honeybees fed from 
these strawberry flowers streptomycete isolates could be 
detected in their guts. Additionally, the isolates could now be 
detected in the flowers of the uncapped, uninoculated plants. 
No Streptomyces spp. were found in the uninoculated capped 
plants, showing that where honeybees had access, they were 
able to transmit Streptomyces bacteria flower to flower.
In short, Kim et al. were able to provide insights into a multi- 
partite interaction between streptomycetes, strawberry plants 
and honeybees. They showed that streptomycete colonize 
strawberry roots and migrate via the xylem to the flowers. 
Here they colonize pollen granules and in turn honeybees 
consuming this pollen are colonized by streptomycetes. As 
the bees travel between flowers, they transmit Streptomyces 
spp. between plants. All the while, streptomycetes provide 
both their plant and insect hosts with protection from disease. 
This study is among the first to demonstrate how Streptomyces 
spp. are able to migrate within a plant host and to observe 
the transmission of endophytic Streptomyces species among 
different hosts. Many questions remain. Which secondary 
metabolites are responsible for protection of the host against 
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fungal and bacterial pathogens? What plant signals govern 
recruitment of streptomycetes, and by what mechanism are 
the bacteria able to traverse the xylem? Is bee gut coloniza-
tion transient, or do the insects acquire Streptomyces spp. 
long term? While much remains to be investigated, Kim et 
al. have provided compelling evidence to support the idea that 
streptomycetes can colonize the phyllosphere and have high-
lighted a fascinating multi- partite interaction. The symbiotic 
relationship between pollinating insects and flowering plants 
is a keystone interaction of crucial ecological importance [71], 
and this study indicates that symbiotic actinomycetes may 
play an important role in this long- studied process.
From the deep sediments of the poles, through the jungles 
of Central America, to the flowers of a strawberry plant and 
the gut of the honeybee, these publications exemplify the 
breadth of habitats for which actinomycetes are adapted. In 
all these cases actinomycetes produced antibiotics, showing 
the breadth of the potential these organisms possess for 
the discovery of novel antibiotics from natural ecosystems, 
further highlighting the importance of preserving these envi-
ronments. As shown through the host- associated systems, 
actinomycetes can be significant ecological partners in these 
ecosystems, displaying intricate co- adaptation with either the 
host or the pathogen.
Technology and methodology
Molecular manipulation of actinomycetes is challenging, 
with even the most basic techniques being more laborious 
and time- consuming than in many other commonly studied 
micro- organisms [72]. There are many useful and powerful 
tools available, or under development, for actinomycete 
research. However, a significant amount of contemporary 
work has become underpinned by two technologies. The 
first is long- read, next- generation whole- genome sequencing 
(WGS), such as PacBio and, to a lesser, but ever- increasing 
extent, Oxford Nanopore, which has allowed the accurate 
construction of genomes rich in GC- repetitive regions [9, 73]. 
The second is CRISPR/Cas9- based genome editing technolo-
gies, the first of which, pCRISPomyces-2, was introduced in 
2015 and has allowed for precise, scar- free genome modifica-
tions, deletions and replacements [74].
antiSMASH 5.0: updates to the secondary metabolite 
genome mining pipeline [75]
As mentioned throughout this review, one of the key 
features of actinomycetes are the numerous BGCs in their 
genomes encoding for the biosynthesis of a plethora of 
specialized metabolites. Identification of these clusters has 
become an essential part of the workflow for the discovery 
of novel compounds and in guiding biological and chemical 
characterization [76]. First released in 2011, the antibiotics 
and secondary metabolites analysis shell (antiSMASH) has 
revolutionized the ease of BGC in silico identification [77]. 
This software, available as a web- based application and a 
standalone tool, is capable of identifying and putatively clas-
sifying BGCs from genome sequences provided or within 
its own database. Iterations have since added support for 
independent tools, including the CRISPR sgDNA design 
software CRISPY- web and the Antibiotic Resistance Target 
Seeker (ARTS) [78–80]. The most recent update, antiSMASH 
5.0, introduces numerous new features. The recommended 
mode for BGC detection by antiSMASH is through conserved 
core enzyme co- occurrence identification. In antiSMASH this 
is underpinned by gene cluster rules, which are manually 
curated and validated based upon hidden Markov models 
(HMMs) derived from multiple databases, including the Pfam 
protein family database [75, 81]. Version 5.0 introduces new 
rules and revises current rules to allow the identification of 8 
new biosynthetic types, bringing the total up to 52. These new 
BGC classes include β-lactones, pseudopyronines, radical 
S- adenosylmethionine- associated RiPPs and fungal RiPPs. 
Improvements have been made to type II polyketide synthase 
(PKS) analysis, including prediction of starter unit, elongation 
cycles number and patterns [75].
It is a common occurrence for distinct BGCs to be encoded 
adjacent to each other, especially in actinomycete plasmids 
where numerous clusters can be found side by side. Histori-
cally, antiSMASH has had issues with identifying where one 
BGC ends and another starts, with such circumstances often 
necessitating manual curation of results to separate these 
misconcatenated clusters. Version 5.0 introduces new termi-
nology to better describe results, for example to distinguish 
between neighbouring and true chemical hybrid clusters [75].
In addition to this, antiSMASH 5.0 has undergone a user 
interface (UI) redesign and refactored its entire code, 
migrating from Python 2.7 to Python 3.5–3.7 for longevity, 
stability and subsequently speed. Historically, results would 
be delivered after several hours, and this has been reduced by 
4–11×, leading to job completion within 40 min for a typical 
submission. The UI modernization has increased the accessi-
bility of the results pages, delivering greater detail and interac-
tion capabilities. For example, it is now possible to select BGC 
‘functional’ units such as the core biosynthetic enzymes [75]. 
To newcomers actinomycete research can seem intimidating, 
thus it is vital to lower these walls as a community. The crea-
tors of antiSMASH have taken this and other feedback into 
account, removing the often misinterpreted ClusterFinder 
algorithm from the online version. It is, however, still avail-
able in the more exhaustive downloadable version [75].
It may seem unusual to feature a software version update 
publication, but antiSMASH has been pivotal to actinomy-
cete secondary metabolism research. Each iteration is a step 
towards a comprehensive, and accessible, BGC identification 
and classification tool and thus is featured in the hope of 
highlighting this tool for the wider microbiology community.
Highly efficient DSB-free base editing for streptomycetes 
with CRISPR-BEST [82]
The transition from PCR- targeted gene replacement tech-
niques such as ReDIRECT to contemporary CRISPR- based 
systems has simplified and streamlined in situ manipulation 
of actinomycete genomes [74, 82, 83]. The second featured 
publication for the technology and methodology section 
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introduces a new CRISPR- based tool in response to issues 
arising from Cas9- containing systems such as pCRISPo-
myces-2 [74, 82]. The expression of the Cas9 enzyme, the 
dual RNA- guided DNA endonuclease used to create the 
double- stranded break (DSB), which facilitates the chromo-
somal rearrangements, can be toxic to many actinomycetes, 
leading to undesirable side- effects [84]. The linear nature of 
some actinomycete chromosomes tends to allow the target 
to withstand relatively large rearrangements and deletions, 
especially in arm regions of the chromosome, a problem faced 
by Tong et al. while trying to delete the duplicated kirromycin 
biosynthetic pathways in Streptomyces collinus Tü365 [82, 85].
S. collinus Tü365 encodes the 82 kbp duplicated pathway for 
this BGC in either arm of the chromosome, but deletion of 
a speculated core biosynthetic gene (kirN) from one copy 
of the BGC using the classical Cas9- based system led to 788 
and 630 kb deletions in both the left and right chromosomal 
arms, respectively. In addition, it led to complete loss of 
kirromycin production rather than the intended knock-
down, as both copies of the BGC, and many off- target genes, 
had been lost due to genomic instability resulting from the 
Cas9- induced DSB [82].
To overcome this, Tong et al. develop a new DSB- free 
CRISPR system that utilizes a deaminase- based editor for 
single- nucleotide resolution editing in actinomycetes and 
only requires a 20 nucleotide protospacer to guide editing. 
This CRISPR- Base Editing System (CRISPR- BEST) comes 
in two forms: CRISPR- cBEST, which converts C : G to 
T : A and CRISPR- aBEST for A : T to G : C. Cytidine- 
to- thymidine mutations allow the introduction of STOP 
codons, whilst loss- of- function mutations can be induced 
by single- nucleotide mutations to guanosine [82, 86]. 
Deaminase- based editing systems do not require a DSB; 
deamination can only occur in single- stranded DNA and 
this restriction limits the base pair conversion to the nicked 
strand in the Cas9n : sgRNA : target R- loop region [82, 87]. 
Similar systems have been used with success in human cell 
line editing because these features allow specific editing 
with significantly less chance of off- target effects [88, 89].
These new tools were validated in the model organism 
S. coelicolor A3(2) and the base pair editing efficiency 
conversion of cytidine to thymidine was proven to be the 
most efficient of the four possibilities for CRSIPR- cBEST 
(TC>CC>AC>GC) and thymidine to cytidine for CRISPR- 
aBEST (TA>GA>AA>CA). Off- target effects were quan-
tified using WGS with single- nucleotide polymorphisms 
(SNPs) being mapped to determine meaningful amino acid 
changes. For 2 CRISPR- cBEST strains 34 and 24 meaningful 
mutations were identified (outside the desired effect), 
whilst only 21 and 20 were identified for the 2 CRISPR- 
aBEST- edited strains. Further validation was performed by 
successfully introducing STOP codons into key enzymes 
from four representative BGCs in Streptomyces griseofuscus 
before the system was used to tackle the kirN problem in 
S. collinus Tü365 [82].
Using CRISPy- web (https:// crispy. secondarymetabolites. org), 
which has been updated to be compatible with CRISPR- BEST 
protospacer design, a STOP codon was incorporated into both 
copies of kirN, leading to reduced kirromycin biosynthesis and 
thus reduced inhibitory zones in bioactivity assays. The reduced 
yield of kirromycin was confirmed using LC- MS [81]. For the 
final plasmid delivery system (available at https://www. addgene. 
org/ 131464/), a Csy4- based sgRNA self- processing system was 
included to aid simple multiplex editing. Previous systems 
required individual promoter and terminators for every sgRNA 
included, but the use of Csy4 allows for the incorporation of 
multiple snRNAs under a single promoter and terminator 
[82, 90].
Technology and methodology are the basis of modern research 
and when dealing with fastidious micro- organisms such as 
actinomycetes even small advances can significantly ameliorate 
day- to- day work. You can see in Fig. 2 that the processes here 
not only complement each other but also enhance the standard 
workflow. At the time of writing, it remains to be seen what 2020 
Fig. 2. Graphic showing the general antibiotic compound discovery 
pipeline. The process usually begins with the isolation of novel strains 
or DNA from environmental samples. Once genomes and metagenomes 
are sequenced and assembled, the sequences can be analysed with 
tools such as RiPPER, antiSMASH or ARTS to identify biosynthetic 
gene clusters (BGCs). A combination of cluster synthesis, cloning and 
heterologous expression, or strain manipulation through CRISPR or 
varied conditions, can then be used to encourage the production of 
novel antibiotics. The production of antibiotics is screened for using 
bioactivity assays. Compounds can then be further characterized using 
techniques such as NMR or mass spectrometry.
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brings in terms of technological and methodological advance-
ments for actinomycete research, but it is truly exciting to see 
the outcomes of tools presented in 2019.
FUTURE PROSPECTS
Recent advances in genomic sequencing as well as the develop-
ment of more sophisticated genome mining and bioinformatic 
tools mean that there is a promising future for natural product 
discovery from actinomycetes. It has long been known that 
>99 % of bacteria cannot be cultivated [91] and that the cultiva-
tion of actinomycetes remains a challenge, especially for rarer 
and highly specialized strains. One approach to overcome this 
is the utilization of novel isolation devices such as the ichip, 
which has been shown to increase microbial recovery from 5- 
to 300- fold [92]. Alternatively, cultivation can be circumnavi-
gated by using metagenomics [93]. This culture- independent 
approach can enable researchers to recover entire genomes 
from the environment. In combination with antiSMASH and 
other recently developed tools [31, 80, 94], this approach could 
identify novel putative BGCs from unculturable microbes, 
which could then be expressed heterologously in a model host 
organism [95]. The development of databases such as Global 
Natural Products Social Molecular Networking (GNPS) then 
allows for in- depth analysis of microbial metabolomic data to 
aid discovery [96].
Combined, these approaches have the potential to help 
revitalize antibiotic discovery in the future, which in turn 
drives the investigation into other key areas of actinomycete 
research, including developmental biology, ecological interac-
tions and methodology expansion.
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